Skip to main content
. 2021 Jun 2;30(1):19–27. doi: 10.4062/biomolther.2021.047

Table 2.

Fourth-generation EGFR inhibitors

Compound Structure Clinical trails Reference
BLU-945 Undisclosed Phase 1 Schalm et al., 2020
BBT-176 Undisclosed Phase 1